DexCom
DXCM
Collegium Pharmaceutical
COLL
Lantheus
LNTH
Cars.com
CARS
YETI Holdings
YETI
US Stock MarketDetailed Quotes
INMB INmune Bio
- 5.295
- +0.365+7.40%
Close Jan 3 16:00 ET
- 5.210
- -0.085-1.61%
Post 18:42 ET
117.80MMarket Cap-2.43P/E (TTM)
5.420High5.010Low408.68KVolume5.010Open4.930Pre Close2.13MTurnover2.84%Turnover RatioLossP/E (Static)22.25MShares14.74052wk High3.05P/B76.17MFloat Cap4.32052wk Low--Dividend TTM14.39MShs Float30.370Historical High--Div YieldTTM8.32%Amplitude2.200Historical Low5.211Avg Price1Lot Size
INmune Bio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -19.76%33.55M | -35.04%31.07M | -49.02%26M | -31.26%35.85M | -31.26%35.85M | -27.16%41.81M | -21.87%47.83M | -23.57%51M | -30.29%52.15M | -30.29%52.15M |
| -Cash and cash equivalents | -19.76%33.55M | -35.04%31.07M | -49.02%26M | -31.26%35.85M | -31.26%35.85M | -27.16%41.81M | -21.87%47.83M | -23.57%51M | -30.29%52.15M | -30.29%52.15M |
| Receivables | -37.25%1.42M | 66.81%3.41M | 21.72%2.69M | -71.14%2.44M | -71.14%2.44M | -50.06%2.26M | -59.57%2.05M | -60.87%2.21M | 53.72%8.46M | 53.72%8.46M |
| -Taxes receivable | -37.25%1.42M | 66.81%3.41M | 21.72%2.69M | -71.14%2.44M | -71.14%2.44M | -50.06%2.26M | -59.57%2.05M | -60.87%2.21M | 53.72%8.46M | 53.72%8.46M |
| Prepaid assets | --15K | --0 | -34.29%23K | 317.65%142K | 317.65%142K | --0 | -99.30%30K | -99.25%35K | 142.86%34K | 142.86%34K |
| Other current assets | -43.71%864K | -62.58%1.01M | -69.47%1.11M | -62.50%1.51M | -62.50%1.51M | --1.54M | --2.71M | --3.63M | 76.78%4.03M | 76.78%4.03M |
| Total current assets | -21.40%35.85M | -32.53%35.5M | -47.57%29.82M | -38.24%39.94M | -38.24%39.94M | -31.57%45.61M | -25.43%52.61M | -26.19%56.88M | -21.71%64.68M | -21.71%64.68M |
| Non current assets | ||||||||||
| Net PPE | -24.55%335K | -22.44%363K | -19.79%389K | -18.34%414K | -18.34%414K | -16.07%444K | -28.00%468K | -28.78%485K | -30.17%507K | -30.17%507K |
| -Gross PPE | -24.55%335K | -22.44%363K | -19.79%389K | -18.34%414K | -18.34%414K | -16.07%444K | -28.00%468K | -28.78%485K | -30.17%507K | -30.17%507K |
| Goodwill and other intangible assets | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M |
| -Other intangible assets | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M | 0.00%16.51M |
| Other non current assets | -36.43%82K | -37.69%81K | 7.07%106K | 32.32%131K | 32.32%131K | 30.30%129K | 31.31%130K | 0.00%99K | 0.00%99K | 0.00%99K |
| Total non current assets | -0.91%16.93M | -0.90%16.96M | -0.52%17.01M | -0.36%17.06M | -0.36%17.06M | -0.32%17.09M | -0.87%17.11M | -1.13%17.1M | -1.26%17.12M | -1.26%17.12M |
| Total assets | -15.82%52.78M | -24.77%52.45M | -36.69%46.83M | -30.31%57M | -30.31%57M | -25.18%62.7M | -20.60%69.72M | -21.59%73.98M | -18.16%81.8M | -18.16%81.8M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | --10.65M | --9.42M | ---- | 52.18%7.94M | 52.18%7.94M | ---- | ---- | ---- | 36.77%5.22M | 36.77%5.22M |
| -accounts payable | --10.65M | --9.42M | ---- | 52.18%7.94M | 52.18%7.94M | ---- | ---- | ---- | 36.77%5.22M | 36.77%5.22M |
| Current debt and capital lease obligation | -73.99%2.63M | -49.42%5.11M | -0.34%7.58M | 97.37%10.04M | 97.37%10.04M | 282.22%10.11M | 8,838.94%10.1M | 9,175.61%7.61M | 6,965.28%5.09M | 6,965.28%5.09M |
| -Current debt | -75.06%2.49M | -50.21%4.98M | -0.60%7.46M | 98.42%9.92M | 98.42%9.92M | 300.00%10M | --10M | --7.5M | --5M | --5M |
| -Current capital lease obligation | 27.36%135K | 28.71%130K | 17.92%125K | 36.78%119K | 36.78%119K | -26.39%106K | -10.62%101K | 29.27%106K | 20.83%87K | 20.83%87K |
| Current deferred liabilities | 10.69%549K | -6.96%521K | -12.01%520K | -20.62%489K | -20.62%489K | -36.25%496K | 17.65%560K | 1.20%591K | 29.96%616K | 29.96%616K |
| Current liabilities | -3.71%13.82M | 15.29%15.05M | 69.70%17.45M | 69.12%18.47M | 69.12%18.47M | 108.21%14.36M | 471.33%13.06M | 218.75%10.28M | 150.47%10.92M | 150.47%10.92M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -89.88%284K | -93.91%322K | -95.36%360K | -96.12%397K | -96.12%397K | -77.97%2.81M | -65.27%5.29M | -48.93%7.76M | -32.57%10.22M | -32.57%10.22M |
| -Long term debt | ---- | ---- | ---- | ---- | ---- | -80.41%2.38M | -66.91%4.82M | -49.95%7.26M | -32.93%9.7M | -32.93%9.7M |
| -Long term capital lease obligation | -33.95%284K | -30.45%322K | -27.71%360K | -24.52%397K | -24.52%397K | -29.16%430K | -28.22%463K | -27.19%498K | -25.28%526K | -25.28%526K |
| Non current accrued expenses | ---- | ---- | ---- | --0 | --0 | 73.65%804K | 93.60%726K | 122.30%638K | 176.38%550K | 176.38%550K |
| Total non current liabilities | -92.13%284K | -94.64%322K | -95.71%360K | -96.31%397K | -96.31%397K | -72.65%3.61M | -61.45%6.01M | -45.75%8.4M | -29.87%10.77M | -29.87%10.77M |
| Total liabilities | -21.48%14.11M | -19.37%15.37M | -4.67%17.81M | -13.04%18.86M | -13.04%18.86M | -10.59%17.97M | 6.66%19.07M | -0.15%18.68M | 9.99%21.69M | 9.99%21.69M |
| Shareholders'equity | ||||||||||
| Share capital | -97.31%22K | 4,450.00%819K | 4,438.89%817K | 4,438.89%817K | 4,438.89%817K | 4,438.89%817K | 0.00%18K | 0.00%18K | 0.00%18K | 0.00%18K |
| -common stock | -97.31%22K | 4,450.00%819K | 4,438.89%817K | 4,438.89%817K | 4,438.89%817K | 4,438.89%817K | 0.00%18K | 0.00%18K | 0.00%18K | 0.00%18K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -36.65%-153.89M | -36.27%-141.79M | -35.36%-132.05M | -32.97%-121.02M | -32.97%-121.02M | -32.21%-112.61M | -34.34%-104.05M | -38.14%-97.55M | -42.85%-91.01M | -42.85%-91.01M |
| Paid-in capital | 23.09%193.58M | 15.04%178.77M | 4.81%160.92M | 4.84%159.14M | 4.84%159.14M | 4.83%157.26M | 4.95%155.4M | 5.03%153.54M | 5.47%151.8M | 5.47%151.8M |
| Gains losses not affecting retained earnings | -40.95%-1.04M | -0.14%-713K | 5.51%-669K | -14.31%-799K | -14.31%-799K | 35.64%-735K | -1.57%-712K | -1,364.29%-708K | -70,000.00%-699K | -70,000.00%-699K |
| Total stockholders'equity | -13.54%38.68M | -26.80%37.08M | -47.51%29.02M | -36.54%38.14M | -36.54%38.14M | -29.78%44.73M | -27.57%50.65M | -26.90%55.3M | -25.08%60.1M | -25.08%60.1M |
| Total equity | -13.54%38.68M | -26.80%37.08M | -47.51%29.02M | -36.54%38.14M | -36.54%38.14M | -29.78%44.73M | -27.57%50.65M | -26.90%55.3M | -25.08%60.1M | -25.08%60.1M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |